Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Journal of the European Academy of Dermatology and Venereology : JEADV - (2024) vom: 20. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rompoti, Natalia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 20.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1111/jdv.19956 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369962044 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369962044 | ||
| 003 | DE-627 | ||
| 005 | 20240320235658.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240320s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jdv.19956 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM369962044 | ||
| 035 | |a (NLM)38506605 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rompoti, Natalia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 650 | 4 | |a Letter | |
| 700 | 1 | |a Stefanaki, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Panagakis, Pantelis |e verfasserin |4 aut | |
| 700 | 1 | |a Papoutsaki, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Politou, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Vavouli, Charitomeni |e verfasserin |4 aut | |
| 700 | 1 | |a Befon, Angeliki |e verfasserin |4 aut | |
| 700 | 1 | |a Kousta, Fiori |e verfasserin |4 aut | |
| 700 | 1 | |a Lazou, Eleni |e verfasserin |4 aut | |
| 700 | 1 | |a Zaimi, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Koumprentziotis, Ioannis-Alexios |e verfasserin |4 aut | |
| 700 | 1 | |a Chasapi, Vasiliki |e verfasserin |4 aut | |
| 700 | 1 | |a Rigopoulos, Dimitrios |e verfasserin |4 aut | |
| 700 | 1 | |a Stratigos, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Nicolaidou, Electra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the European Academy of Dermatology and Venereology : JEADV |d 1997 |g (2024) vom: 20. März |w (DE-627)NLM091705932 |x 1468-3083 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:20 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jdv.19956 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 20 |c 03 | ||